We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
STA Pharmaceutical, a US subsidiary of China-based company WuXi AppTec, has signed a new supply agreement with oncology-focused biopharmaceutical company Tesaro for certain starting and intermediate materials for zejula (niraparib).